| Market Cap | 348.69M | P/E | 20.28 | EPS this Y | - | Ern Qtrly Grth | -17.80% |
| Income | 15.63M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 1.00% |
| Sales | 46.58M | PEG | - | EPS past 5Y | 22.01% | 200D Avg Chg | 3.00% |
| Dividend | 1.00% | Price/Book | 2.86 | EPS next 5Y | - | 52W High Chg | -12.00% |
| Recommedations | - | Quick Ratio | 23.58 | Shares Outstanding | 3.48M | 52W Low Chg | 19.00% |
| Insider Own | 6.72% | ROA | 8.44% | Shares Float | 3.02M | Beta | 0.08 |
| Inst Own | 72.48% | ROE | 12.72% | Shares Shorted/Prior | 63.81K/49K | Price | 96.11 |
| Gross Margin | 58.99% | Profit Margin | 33.56% | Avg. Volume | 10,885 | Target Price | - |
| Oper. Margin | 39.16% | Earnings Date | Oct 24 | Volume | 12,220 | Change | -2.11% |
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO, an umbilical vessel catheters, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation devices; suprapubic catheterization; LIBERTY, an urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| RICHINS PAUL O | Director Director | May 18 | Sell | 93.47 | 700 | 65,429 | 21,461 | 05/19/23 |
| RICHINS PAUL O | Director Director | Nov 17 | Sell | 90 | 161 | 14,490 | 22,760 | 11/17/22 |
| RICHINS PAUL O | Director Director | Nov 11 | Sell | 92.5 | 40 | 3,700 | 22,921 | 11/15/22 |
| PAYNE BARBARA A | Director Director | May 11 | Sell | 85.1983 | 2,000 | 170,397 | 5,338 | 05/11/22 |
| HOYER ERNST G | Director Director | Nov 23 | Sell | 125.71 | 5,000 | 628,550 | 5,000 | 11/26/21 |
| PAYNE BARBARA A | Director Director | Nov 17 | Sell | 111.06 | 2,000 | 222,120 | 7,838 | 11/18/21 |